ArticleMayo Clinic proceedings. Innovations, quality & outcomes2019
Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population.
Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis.Journal of medical screening · 2023Pooled it
- Urban-rural disparities in lung cancer incidence and mortality patterns in Black and White populations.Cancer · 2025Article
- Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.JAMA network open · 2023Article
- Effective Educational Approaches to Training Physicians About Lung Cancer Screening.Journal of cancer education : the official journal of the American Association for Cancer Education · 2022Article
- Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients.Cancer medicine · 2021Article
- State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States.Journal of the National Cancer Institute · 2021Article
- Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer.BMC cancer · 2020Article
- Bivariate Spatial Pattern between Smoking Prevalence and Lung Cancer Screening in US Counties.International journal of environmental research and public health · 2020Article
- Integrated, Multidisciplinary Management of Pulmonary Nodules Can Streamline Care and Improve Adherence to Recommendations.The oncologist · 2020Article
- Evaluating Potential Racial Inequities in Low-dose Computed Tomography Screening for Lung Cancer.Journal of the National Medical Association · 2020Article
- Article
- Article
- Tobacco Cessation, Rural Residence, and Lung Cancer.Journal of environment and health sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
objectiveTo describe rates of low-dose computed tomography (LDCT) and all chest computerized tomography (CT) before and after Centers for Medicare and Medicaid Services (CMS) initiated reimbursement and requirements for screening and to describe factors associated with receipt of LDCT. PATIENTS AND
methodsRetrospective cross-sectional study of Medicare enrollees aged 55 to 77 in Parts A and B Medicare without HMO enrollment in a 20% national sample (n=3,887,430 in 2010, 4,200,875 in 2015, and 4,145,542 in 2016). The outcomes were receipt of LDCT and any chest CT from January 1, 2010, to December 31, 2016. Other measures included enrollee demographic characteristics and diagnoses, including diagnoses of tobacco use.
resultsThe number of enrollees aged 55 to 77 with LDCT rose throughout 2015 and early 2016, and then plateaued. In 2016, 0.44% of enrollees, and 2.21% of those with a tobacco-use diagnosis, underwent LDCT screening. There were increases in the rate of any chest CT (LDCT or diagnostic) between January 1, 2010 and December 31, 2016, and most of this was accounted for by LDCTs.
conclusionsTwo years after CMS approval for lung cancer screening reimbursement, less than 5% of the Medicare population eligible for screening received LDCT. More work is required to identify and modify the barriers for LDCT screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.